Arrowhead Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for…

Biotechnology
US, Pasadena [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ARWR's Analysis
CIK: 879407 CUSIP: 04280A100 ISIN: US04280A1007 LEI: - UEI: -
Secondary Listings
ARWR has no secondary listings inside our databases.